Surya Bhanupratap Singh #
Introduction #
Surya Bhanupratap Singh is an Indian wushu athlete from Jammu & Kashmir who competes in Sanda, a discipline in which he won bronze at the 2018 Jakarta Asian Games and twice finished third at the World Wushu Championships. On September 2, 2026, the 30-year-old became the latest Indian athlete caught in a widening pre-Games doping wave, when reports by the Times of India and Sporting News revealed that the National Anti-Doping Agency (NADA) had provisionally suspended him after he failed an anti-doping test for Enobosarm, the banned substance better known as Ostarine. The consequence was immediate: dropped from the Asian Games squad, his name was deleted from the government-approved final contingent for the Aichi-Nagoya Games, stripping India of one of its strongest wushu medal prospects weeks before the event was due to open on September 19, 2026.
Background Information #
Bhanupratap, a 30-year-old from Jammu & Kashmir, built his reputation as one of India’s most consistent Sanda exponents. He is a two-time World Wushu Championships bronze medallist, having finished third in the 60kg category at Jakarta in 2015 and again at Kazan in 2017. His finest competitive result came at the 2018 Asian Games in Jakarta, where he took bronze in the men’s 60kg Sanda event. Moving up in weight, he had been tipped as a strong contender for a medal in the men’s 65kg Sanda event at the 2026 Asian Games in Aichi-Nagoya, which were scheduled to run from September 19 to October 4, 2026.
The Controversy or Incident That Led to Their Cancellation #
Adverse finding. The accounts below describe a provisional suspension imposed after a failed dope test. Neither report indicates that NADA’s disciplinary process has concluded or that any sanction has been adjudicated; what is documented is the provisional suspension and his removal from the contingent.
According to the Times of India, whose report by Sabi Hussain was published on September 2, 2026, Bhanupratap failed an anti-doping test for Enobosarm (Ostarine), a selective androgen receptor modulator (SARM) designed for muscle and bone development. Ostarine is strictly prohibited by the World Anti-Doping Agency (WADA) and is classified under category S1.2, “other anabolic agents”. Sporting News, citing the Times of India, likewise reported that Bhanupratap had been found consuming Enobosarm, describing it as a selective androgen receptor modulator typically used to build muscle and strengthen bone density that sits firmly on WADA’s banned list under S1.2. Following the adverse finding, NADA provisionally suspended him, he was dropped from the Asian Games squad, and his name was deleted from the government-approved final contingent for the Games. Sporting News reported the same formal step, noting that with the suspension in place his name had been struck from the government-approved contingent.
Public Reaction and Consequences #
The case landed at a particularly sensitive moment in India’s preparations. The Times of India framed it under the headline “Another dope case clouds India’s preparations”, and editorialized that the latest case underlines the growing challenge for NADA and Indian sports authorities as they try to keep doping cheats out of Games squads. Bhanupratap’s positive test took the number of Indian athletes failing dope tests since the recent Glasgow Commonwealth Games to 12, an alarming spurt that has affected multiple disciplines and, in some cases, cost India competition quotas. The other athletes on the list span weightlifting (N Ajith, Sairaj Pardeshi, Harcharan Singh, Vanshita Verma), judo (Arun Kumar, Tulika Maan), shooting (Gaurav Kumar Masoori), rowing (Lakshya), wrestling (Mukul Dahiya, Deepanshu) and athletics (Abhishek Pal), with Bhanupratap the latest addition and the only wushu athlete. The wave has already reshaped other squads: India named only five lifters for Aichi-Nagoya — Mirabai Chanu, Gyaneshwari Yadav, Seram Nirupama Devi, Harjinder Kaur and Rishikanta Singh — after Glasgow quota violations, and wrestling’s allocation shrank from 18 spots to 16 after the suspensions of Dahiya and Deepanshu. In wushu, Bhanupratap’s exclusion trimmed India’s squad for the Games to seven athletes.
Current Status #
As of the September 2, 2026 reporting, Bhanupratap remains under provisional NADA suspension, and his name has been deleted from the government-approved final contingent for the Aichi-Nagoya Asian Games. Neither report indicates that the anti-doping process against him has reached a final adjudication, and neither quotes him responding to the case. His exclusion is described as confirmed in the practical sense that matters for the Games: with his name formally struck from the contingent, India’s wushu representation stands at seven athletes, and the event he was training for was due to begin on September 19, 2026, in Japan.
Impact on Their Career/Life #
The suspension removed, at age 30, what both reports describe as a genuine medal opportunity: the Times of India called him a strong medal prospect in the men’s 65kg Sanda event, and Sporting News counted him among the country’s medal hopes in wushu, making his loss a direct competitive blow to India’s contingent. The episode also recast the legacy of a career that had yielded three major international bronzes — the 2015 and 2017 world championship medals and the 2018 Asian Games podium — by attaching it to India’s most consequential doping cluster in the build-up to a major Games, a list of twelve athletes whose cases, per the Times of India, have in some instances cost India competition quotas outright. Whether the provisional suspension hardens into a formal sanction rests with the pending NADA process, which had not produced any published outcome at the time of the reports.